You just read:

BridgeBio Pharma Appoints Sanuj Ravindran, M.D., and Eric Michael David, M.D. as CEOs-in-Residence to Lead Dermatology and Gene Therapy Programs

News provided by

BridgeBio Pharma

Jan 04, 2018, 08:00 ET